Institutional Ownership Vertex Pharmaceuticals Inc (VRTX)
This table provides information about the institutional ownership of Vertex Pharmaceuticals Inc (VRTX). We have compiled data on the 1,791 institutions that hold shares in the stock, with a total of 231 Million shares, which have been reported (via 13F filing form) to have a value of $100 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Capital World Investors
Los Angeles, CA |
Nov 13, 2025 Q3 2025 |
25,910,587
shares
|
$11.2 Billion
1.45% of portfolio
|
Q3 2025
Reduced 9.82%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
24,216,865
shares
|
$10.5 Billion
0.15% of portfolio
|
Q3 2025
Added 1.01%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
21,312,244
shares
|
$9.25 Billion
0.23% of portfolio
|
Q2 2024
Reduced 2.95%
|
|
|
Capital Research Global Investors
Los Angeles, CA |
Nov 13, 2025 Q3 2025 |
16,553,281
shares
|
$7.18 Billion
1.27% of portfolio
|
Q3 2025
Added 2.76%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
11,606,000
shares
|
$5.04 Billion
0.16% of portfolio
|
Q3 2025
Reduced 1.44%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 26, 2025 Q3 2025 |
6,434,778
shares
|
$2.79 Billion
0.17% of portfolio
|
Q3 2025
Reduced 17.03%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
5,973,745
shares
|
$2.59 Billion
0.15% of portfolio
|
Q3 2025
Added 0.76%
|
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2025 Q3 2025 |
4,772,042
shares
|
$2.07 Billion
0.34% of portfolio
|
Q3 2025
Reduced 0.86%
|
|
|
Capital International Investors
Los Angeles, CA |
Nov 13, 2025 Q3 2025 |
4,689,059
shares
|
$2.04 Billion
0.31% of portfolio
|
Q3 2025
Added 77.89%
|
|
|
Alliancebernstein L.P.
New York, NY |
Nov 14, 2025 Q3 2025 |
4,522,586
shares
|
$1.96 Billion
0.59% of portfolio
|
Q3 2025
Added 3.3%
|
|
|
Loomis Sayles & CO L P
|
Nov 13, 2025 Q3 2025 |
4,122,128
shares
|
$1.79 Billion
1.98% of portfolio
|
Q3 2025
Added 8.1%
|
|
|
Jennison Associates LLC
|
Oct 30, 2025 Q3 2025 |
3,454,947
shares
|
$1.5 Billion
0.79% of portfolio
|
Q3 2025
Reduced 43.84%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
3,108,405
shares
|
$1.35 Billion
0.08% of portfolio
|
Q3 2025
Reduced 6.69%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
3,043,805
shares
|
$1.32 Billion
0.13% of portfolio
|
Q3 2025
Reduced 3.67%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2025 Q3 2025 |
2,887,117
shares
|
$1.25 Billion
0.25% of portfolio
|
Q3 2025
Reduced 5.88%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2025 Q3 2025 |
2,840,424
shares
|
$1.23 Billion
0.08% of portfolio
|
Q3 2025
Added 1.17%
|
|
|
Clearbridge Investments, LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
2,645,764
shares
|
$1.15 Billion
0.82% of portfolio
|
Q3 2025
Added 73.17%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
2,627,887
shares
|
$1.14 Billion
0.14% of portfolio
|
Q3 2025
Reduced 1.15%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Nov 14, 2025 Q3 2025 |
2,276,927
shares
|
$988 Million
0.22% of portfolio
|
Q3 2025
Added 4.38%
|
|
|
Victory Capital Management Inc
|
Nov 12, 2025 Q3 2025 |
2,247,566
shares
|
$975 Million
0.58% of portfolio
|
Q3 2025
Added 4.29%
|
|
|
Janus Henderson Group PLC
London, X0 |
Nov 14, 2025 Q3 2025 |
2,119,107
shares
|
$920 Million
0.4% of portfolio
|
Q3 2025
Reduced 19.1%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 13, 2025 Q3 2025 |
2,096,797
shares
|
$910 Million
0.14% of portfolio
|
Q3 2025
Added 5.68%
|
|
|
Legal & General Group PLC
London, X0 |
Nov 13, 2025 Q3 2025 |
1,952,297
shares
|
$847 Million
0.18% of portfolio
|
Q3 2025
Added 3.31%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 10, 2025 Q3 2025 |
1,829,931
shares
|
$794 Million
0.12% of portfolio
|
Q3 2025
Added 3.17%
|
|
|
Parnassus Investments, LLC
|
Oct 24, 2025 Q3 2025 |
1,648,433
shares
|
$715 Million
1.57% of portfolio
|
Q3 2025
Reduced 3.68%
|
|